A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 295,321 shares of MRNA stock, worth $10.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
295,321
Previous 304,256 2.94%
Holding current value
$10.9 Million
Previous $36.1 Million 45.38%
% of portfolio
0.05%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$63.64 - $125.14 $568,623 - $1.12 Million
-8,935 Reduced 2.94%
295,321 $19.7 Million
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $30.8 Million - $50.7 Million
304,256 New
304,256 $36.1 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.